» Articles » PMID: 37071027

Remote Activity Monitoring and Electronic Patient-Reported Outcomes Collection During Radiotherapy for Head and Neck Cancer: A Pilot Study

Overview
Date 2023 Apr 18
PMID 37071027
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Modern wearable devices provide objective and continuous activity data that could be leveraged to enhance cancer care. We prospectively studied the feasibility of monitoring physical activity using a commercial wearable device and collecting electronic patient-reported outcomes (ePROs) during radiotherapy (RT) for head and neck cancer (HNC).

Methods: Patients planned for a course of external beam RT with curative intent for HNC were instructed to use a commercial fitness tracker throughout the RT course. During weekly clinic visits, physician-scored adverse events were recorded during using Common Terminology Criteria for Adverse Events version 4.0, and patients completed ePRO surveys using a clinic tablet or computer. Feasibility of activity monitoring was defined as collection of step data for at least 80% of the RT course for at least 80% of patients. Exploratory analyses described associations between step counts, ePROs, and clinical events.

Results: Twenty-nine patients with HNC were enrolled and had analyzable data. Overall, step data were recorded on 70% of the days during patients' RT courses, and there were only 11 patients (38%) for whom step data were collected on at least 80% of days during RT. Mixed effects linear regression models demonstrated declines in daily step counts and worsening of most PROs during RT. Cox proportional hazards models revealed a potential association between high daily step counts and both reduced risk of feeding tube placement (hazard ratio [HR], 0.87 per 1,000 steps, < .001) and reduced risk of hospitalization (HR, 0.60 per 1,000 steps, < .001).

Conclusion: We did not achieve our feasibility end point, suggesting that rigorous workflows are required to achieve continuous activity monitoring during RT. Although limited by a modest sample size, our findings are consistent with previous reports indicating that wearable device data can help identify patients who are at risk for unplanned hospitalization.

References
1.
Ohri N, Kabarriti R, Bodner W, Mehta K, Shankar V, Halmos B . Continuous Activity Monitoring During Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2017; 97(5):1061-1065. PMC: 5364815. DOI: 10.1016/j.ijrobp.2016.12.030. View

2.
Han H, Hermann G, Ma S, Iovoli A, Wooten K, Arshad H . Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patients. Oral Oncol. 2020; 109:104854. PMC: 7738364. DOI: 10.1016/j.oraloncology.2020.104854. View

3.
McCloskey S, Jaggernauth W, Rigual N, Hicks Jr W, Popat S, Sullivan M . Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of.... Am J Clin Oncol. 2009; 32(6):587-91. DOI: 10.1097/COC.0b013e3181967dd0. View

4.
Barber E, Garg R, Strohl A, Roque D, Tanner E . Feasibility and Prediction of Adverse Events in a Postoperative Monitoring Program of Patient-Reported Outcomes and a Wearable Device Among Gynecologic Oncology Patients. JCO Clin Cancer Inform. 2022; 6:e2100167. PMC: 9848580. DOI: 10.1200/CCI.21.00167. View

5.
Jim H, Hoogland A, Brownstein N, Barata A, Dicker A, Knoop H . Innovations in research and clinical care using patient-generated health data. CA Cancer J Clin. 2020; 70(3):182-199. PMC: 7488179. DOI: 10.3322/caac.21608. View